Innovent treats first cancer patient in Phase I clinical trial of Anti-OX40 Antibody
Mayne Pharma unveils Lexette (halobetasol propionate) foam 0.05% in the US plaque psoriasis market
US FDA posts warning letters to companies illegally selling more than 58 products
Parexel Appoints Former FDA Senior Executives to Global Regulatory Consulting Services
US Patent Issued for AXA Candidate AXA1125
Omeros Names Bumol to Board of Directors
Calliditas Therapeutics announces grant of ODD by US FDA for primary biliary cholangitis
Harmony Biosciences submits Pitolisant NDA with US FDA under priority review